7月 2026
- 首頁
- CN Bio
7月 2026CN Bio的市場佔有率分析
Leave primary human cell validation to the experts. Without quality controlled 3D validated human cells your experiments won't deliver reliable data. Speak to us today.
CN Bio(包含公司地區)
查看更多網站流量與參與度資訊- cn-bio.com
CN Bio截至 7月 2026 的總收入為 2M - 5M
CN Bio 熱門網域產生的總收入
CN Bio 熱門網域 3 年內的總收入
CN Bio 熱門網域的總收入
CN Bio的熱門網域總造訪量
了解CN Bio市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
CN Bio的熱門網域平均造訪時長
分析CN Bio參與度指標。
過去 3 個月平均造訪時長
子公司細目
CN Bio的熱門網域平均頁面瀏覽量
了解CN Bio如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自CN Bio
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Cn Bio received financing of $243K in Innovate UK grant on Aug 12th '26.CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced it has been awarded £180k grant funding from Innovate UK.
8月 12, 2026閱讀更多
新聞Gregory at CN Bio received award Life Science Company of the Year on Jul 1st '25.Sir Gregory spoke to the audience, before the winners of the other awards were revealed, beginning with Start-up of the Year, which went to TRIMTECH Therapeutics - a company that raised £25m in the largest biotech seed round in the UK last year - and ending with Life Science Company of the Year, which was won by CN Bio, reflecting a pivotal year, during which it led the shift away from animal testing in drug discovery with its PhysioMimix Core organ-on-a-chip platform.
5月 7, 2026閱讀更多
新聞CN Bio launches all-in-one Organ-on-a-chip system.CN Bio launches all-in-one Organ-on-a-chip system,
10月 13, 2025閱讀更多
查看所有CN Bio信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
